- Article
- Source: Campus Sanofi
- May 20, 2025
Burden of Disease
RSV Is a Common Respiratory Virus With Symptoms Varying by Age-Group
.png)
COPD, chronic obstructive pulmonary disease; LRTIs, lower respiratory tract infections; mos, months; yrs, years.
-
Adapted from: Openshaw PJM, et al. Annu Rev Immunol. 2017;35:501-532.
-
Carvajal JJ, et al. Front Immunol. 2019;10:2152.
-
Falsey AR,et al. N Engl J Med. 2005;352(17):1749-1759.
RSV Causes Substantial Disease Burden for Newborns and Infants Globally
.png)
Based on 2019 global data.
-
Li Y, et al. Lancet. 2022 May 19:S0140-6736(22)00478-0. doi: 10.1016/S0140-6736(22)00478-0.
RSV is a Leading Cause of LRTIs Among Infants Worldwide1,2
Estimated Percentage of acute LRTI attributable to RSV infection
.png)
LRTI, lower respiratory tract infection.
Data are derived from different studies and over different years.
aOnly includes hospitalizations due to bronchiolitis; bRSV was a cause of 28% of all hospitalization cases in infants in France.
-
Nair H, et al. Lancet. 2010;375(9725):1545-55.
-
Shi T, et al. Lancet. 2017;390(10098):946-958.
-
Rha B, et al. Pediatrics. 2020;146(1):e20193611.
-
Reeves RM, et al. Influenza Other Respir Viruses. 2017;11(2):122-129.
-
El-Hajje MJ, et al. Eur J Pediatr. 2008;167(4):435-436.
-
Weigl J, et al. Eur J Clin Microbiol Infect Dis. 2001;20(7):452-9.
-
Sanchez-Luna M, et al. Curr Med Res Opin. 2016;32(4):693-698.
-
Cangiano G, et al. Pediatr Pulmonol. 2016;51(12):1330-1335.
-
Zhang Y, et al. J Global Health. 2015;5(2):020417.
-
Inagaki A, et al. Jpn J Infect Dis. 2021;74(1):23-28.
-
Ahmed, A., et al. (2018). "An overview of respiratory syncytial virus infections in Saudi Arabia." The Journal of Infection in Developing Countries 12(11): 929-936
-
Alkharsah, K. R. (2022). "The Scope of Respiratory Syncytial Virus Infection in a Tertiary Hospital in the Eastern Province of Saudi Arabia and the Change in Seasonal Pattern during and after the COVID-19 Pandemic." Medicina 58(11): 1623.
Prevalence in RSV hospitalized with bronchiolitis during seasonal epidemics
aCoronavirus type OC43, 229E, NL63, and HKU1. Age range of children not specified.
-
Meissner HC. N Engl J Med. 2016;374(1):62-72.
-
Al Aql, F., et al. (2016). "Guidelines for palivizumab prophylaxis in infants and young children at increased risk for respiratory syncytial virus infection in Saudi Arabia.
" International Journal of Pediatrics and Adolescent Medicine 3(1): 38-42. -
Elham E, B. and E. Malak M (2013).
"Viral agents causing acute lower respiratory tract infections in hospitalized children at a tertiary care center in Saudi Arabia."
RSV Average Hospitalization days
5.9 days in hospital
6.5 days in hospital
total of 754 beds (502 inpatient beds, 56 emergency beds, 77 ICU beds, 32 psychiatry beds, and 87 special auxiliary beds).
AComorbidities assessed: congenital cardiopathies, 2.3%; congenital defects with cardiac affectation, 0.7%; prematurity, 0.3%; bronchopulmonary dysplasia, 1%.
-
Gil-Prieto R, et al. Medicine (Baltimore). 2015;94(21):e831.,
-
Alkharsah, K. R. (2022).
"The Scope of Respiratory Syncytial Virus Infection in a Tertiary Hospital in the Eastern Province of Saudi Arabia and the Change in Seasonal Pattern during and after the COVID-19 Pandemic." Medicina 58(11): 1623.
RSV Causes Substantial Hospitalization Among All Infants and Young Children In Spain
Epidemiologic survey in Spain estimating the burden of RSV in all children <5 years of age during a 15-year period (1997–2011)1
.png)
326,175
hospital discharges
Due to bronchiolitis in children <5 years of age
.png)
5.9 days
in hospital
on average in children ≤2 years of age
.png)
4,136/100,000 incidence of hospitalization during 1st year of life
highest incidence among all age ranges
.png)
446
deaths
355 (80%)<12 months of age 335 (75%) without comorbidities*
96.8 % of children were otherwise healthy
Only 3.2% of children <5 years of age presented with ≥1 comorbidity*
AComorbidities assessed: congenital cardiopathies, 2.3%; congenital defects with cardiac affectation, 0.7%; prematurity, 0.3%; bronchopulmonary dysplasia, 1%.
-
Gil-Prieto R, et al. Medicine (Baltimore). 2015;94(21):e831.
MAT-BH-2500216-V1-April2025